CMIC Group to Support Clinical Trial, Manufacturing of Avigan for COVID-19 Treatment

April 24, 2020
CMIC Holdings said on April 23 that the CMIC Group will provide contract manufacturing services for Fujifilm’s antiviral Avigan (favipiravir), which is now being investigated as a treatment for COVID-19, in a bid to help the drug maker accelerate its...read more